Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Journal of Colloid and Interface Science|March 26, 2003
Immobilization and surface characterization of NeutrAvidin biotin-binding protein on different hydrogel interlayersPatrick Vermette, Thomas Gengenbach, Upulie Divisekera, et al.Chemical Communications (Cambridge, England)|September 19, 2014
Biological stability and activity of siRNA in ionic liquidsRomiza R Mazid, Upulie Divisekera, Wenjuan Yang, et al.Cancer Research|February 5, 2011
CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasisJohn Stagg, Upulie Divisekera, Helene Duret, et al.Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Anti-CD73 antibody therapy inhibits breast tumor growth and metastasisJohn Stagg, Upulie Divisekera, Nicole McLaughlin, et al.Proceedings of the National Academy of Sciences of the United States of America|April 13, 2011
Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapyJohn Stagg, Sherene Loi, Upulie Divisekera, et al.Cancer Research|March 8, 2012
CD73-deficient mice are resistant to carcinogenesisJohn Stagg, Paul A Beavis, Upulie Divisekera, et al.Proceedings of the National Academy of Sciences of the United States of America|August 22, 2013
Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumorsPaul A Beavis, Upulie Divisekera, Christophe Paget, et al.Pageof 1